CNC
CENTENE CORP
NYSE: CNC · St Louis, MO · Healthcare
$66.21+1.18 (+1.81%)Closed
Market Cap$32.69B
Cash$21.26Bmost recent
Runwayprofitable
P/E (TTM)—EPS $-13.53
52-Wk Range$25.21 – $66.21
Avg Volume9.9M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$66.21-5.2%
Pipeline
Drug candidates sponsored by CENTENE · ClinicalTrials.gov
No trials found for this sponsor.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for CNC. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.